Ability of alpha-lipoic acid to reverse the diabetic cystopathy in a rat model
查看参考文献35篇
文摘
|
Aim: The present study was conducted to investigate whether alpha-lipoic acid (α-LA) is able to reverse impaired bladder function induced by diabetes in a rat model and to explore the possible mechanism mediating the effect. Methods: Male Sprague_Dawley rats were divided randomly into 3 age-matched groups: control, diabetes mellitus (DM) treated with vehicle, and DM with α-LA treatment. The diabetic rats were induced by a single intraperitoneal (ip) injection of streptozotocin (60 mg/kg). Six weeks after the induction of DM, the two groups received another 6 weeks of treatment with vehicle or α-LA (100 mg/kg, ip). Body weight and blood glucose levels were measured weekly. The bladder function was evaluated by in vitro cystometry. The oxidative stress status was determined by biochemical methods, and the level of nerve growth factor was investigated by enzyme-linked immunosorbent assay. Results: The streptozotocin-induced diabetic rats showed impaired bladder function characterized by increased bladder capacity, decreased bladder contractility (voiding efficiency), and an increase in residual urine. Treatment with α-LA significantly normalized the increased bladder capacity for inducing voiding, single-voided volume, and post-void residual volume. α-LA treatment significantly reversed the increased level of malondialdehyde and reduced the activities of both superoxide dismutase and catalase. DM caused a decrease in the bladder nerve growth factor (NGF) level, and α-LA upregulated the level of NGF in the diabetic rat bladder. Conclusion: These results indicate that α-LA has a beneficial effect on diabetes-induced cystopathy by ameliorating oxidative stress and normalizing the NGF level in the bladder. |
来源
|
Acta Pharmacologica Sinica
,2008,29(6):713-719 【核心库】
|
DOI
|
10.1111/j.1745-7254.2008.00790.x
|
关键词
|
alpha-lipoic acid
;
diabetic cystopathy
;
diabetes mellitus
;
neuropathy
;
bladder
;
oxidative stress
;
nerve growth factor
;
rats
|
地址
|
Department of Urology, the First Affiliated Hospital, China Medical University, Shenyang, 110001
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
1671-4083 |
学科
|
药学 |
基金
|
grant from the Education Department of Liaoning Province (No 05L552)
|
文献收藏号
|
CSCD:3301358
|
参考文献 共
35
共2页
|
1.
Brown JS. Urologic complications of diabetes.
Diabetes Care,2005,28:177-185
|
CSCD被引
11
次
|
|
|
|
2.
Yoshimura N. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy.
BJU Int,2005,95:733-738
|
CSCD被引
8
次
|
|
|
|
3.
Bradley WE. Diagnosis of urinary bladder dysfunction in diabetes mellitus.
Ann Intern Med,1980,92:323-326
|
CSCD被引
1
次
|
|
|
|
4.
Ueda T. Diabetic cystopathy:relationship to autonomic neuropathy detected by sympathetic skin response.
J Urol,1997,157:580-584
|
CSCD被引
9
次
|
|
|
|
5.
Sasaki K. Diabetic cystopathy correlates with long-term decrease in nerve growth factor(NGF)levels in the bladder and lumbosacral dorsal root ganglia.
J Urol,2002,168:1259-1264
|
CSCD被引
13
次
|
|
|
|
6.
Sen CK. Thiol homeostasis and supplements in physical exercise.
Am J Clin Nutr,2000,72:S653-S669
|
CSCD被引
1
次
|
|
|
|
7.
Packer L. Molecular aspects of lipoic acid in the prevention of diabetes complications.
Nutrition,2001,17:888-895
|
CSCD被引
32
次
|
|
|
|
8.
Bhatti F. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney.
Kideny Int,2005,67:1371-1380
|
CSCD被引
26
次
|
|
|
|
9.
Shotton HR. Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoid acid and evening primrose oil.
Auton Neurosci,2004,111:57-65
|
CSCD被引
1
次
|
|
|
|
10.
Ziegler D. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy:the SYDNEY 2 trial.
Diabetes Care,2006,29:2365-2370
|
CSCD被引
17
次
|
|
|
|
11.
Ametov AS. The sensory symptoms of diabetic polyneuropathy are improved withα-lipoid acid:the SYDNEY trial.
Diabetes Care,2003,26:770-776
|
CSCD被引
31
次
|
|
|
|
12.
Zini A. Reactive oxygen species in semen of infertile patients:level of superoxide dismutase-and catalase-like activities in seminal plasma and spermatozoa.
Int J Androl,1993,16:183-188
|
CSCD被引
7
次
|
|
|
|
13.
Maritim AC. Diabetes, oxidative stress, and antioxidants:a review.
J Biochem Mol Toxicol,2003,17:24-38
|
CSCD被引
92
次
|
|
|
|
14.
Brownlee M. The pathobiology of diabetic complications:a unifying mechanism.
Diabetes,2005,54:1615-1625
|
CSCD被引
263
次
|
|
|
|
15.
Niedowicz DM. The role of oxidative stress in diabetic complications.
Cell Biochem Biophys,2005,43:289-330
|
CSCD被引
16
次
|
|
|
|
16.
Beshay E. Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model.
Urology,2004,64:1062-1067
|
CSCD被引
7
次
|
|
|
|
17.
Baydas G. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus.
J Pineal Res,2002,32:225-230
|
CSCD被引
11
次
|
|
|
|
18.
Sena CM. Endothelial dysfunction in type 2 diabetes:effect of antioxidants.
Rev Port Cardiol,2007,26:609-619
|
CSCD被引
7
次
|
|
|
|
19.
Halliwell B. Lipid peroxidation:its mechanism, measurements and significance.
Am J Clin Nut,1993,57:S715-S725
|
CSCD被引
57
次
|
|
|
|
20.
Kakkar R. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats.
Mol Cell Biochem,1995,151:113-119
|
CSCD被引
6
次
|
|
|
|
|